ANTs and cancer: Emerging pathogenesis, mechanisms, and perspectives

Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188485. doi: 10.1016/j.bbcan.2020.188485. Epub 2020 Dec 11.

Abstract

Adenine nucleotide translocases (ANTs) are a class of transporters located in the inner mitochondrial membrane that not only couple processes of cellular productivity and energy expenditure, but are also involved in the composition of the mitochondrial membrane permeability transition pore (mPTP). The function of ANTs has been found to be most closely related to their own conformational changes. Notably, as multifunctional proteins, ANTs play a key role in oncogenesis, which provides building blocks for tumor anabolism, control oxidative phosphorylation and glycolysis homeostasis, and govern cell death. Thus, ANTs constitute promising targets for the development of novel anticancer agents. Here, we review the recent findings regarding ANTs and their important mechanisms in cancer, with a focus on the therapeutic potential of targeting ANTs for cancer therapy.

Keywords: ADP/ATP transporter; ANTs; Carcinogenesis; Targeted therapy; mPTP.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Carcinogenesis / genetics*
  • Carcinogenesis / metabolism
  • Cell Membrane Permeability / genetics
  • Cell Transformation, Neoplastic / genetics*
  • Cell Transformation, Neoplastic / metabolism
  • Energy Metabolism / genetics
  • Glycolysis / genetics
  • Humans
  • Mitochondria / genetics
  • Mitochondria / metabolism
  • Mitochondrial ADP, ATP Translocases / genetics*
  • Mitochondrial Permeability Transition Pore / metabolism
  • Neoplasms / genetics*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Oxidative Phosphorylation

Substances

  • Mitochondrial Permeability Transition Pore
  • Mitochondrial ADP, ATP Translocases